BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Otto SP, Day T, Arino J, Colijn C, Dushoff J, Li M, Mechai S, Van Domselaar G, Wu J, Earn DJD, Ogden NH. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Curr Biol 2021;31:R918-29. [PMID: 34314723 DOI: 10.1016/j.cub.2021.06.049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Carroll T, Fox D, van Doremalen N, Ball E, Morris MK, Sotomayor-Gonzalez A, Servellita V, Rustagi A, Yinda CK, Fritts L, Port JR, Ma ZM, Holbrook M, Schulz J, Blish CA, Hanson C, Chiu CY, Munster V, Stanley S, Miller CJ. The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters. bioRxiv 2021:2021. [PMID: 34462750 DOI: 10.1101/2021.08.25.457626] [Reference Citation Analysis]
2 Ye ZW, Fan Y, Tang K, Ong CP, Luo C, Chung HL, Leong TL, Liang R, Lui WY, Zhou R, Cheng Y, Lu L, Cheung PH, Chan JF, Chen Z, Yuen KY, Yuan S, To KK, Jin DY. Cross-variant protection against SARS-CoV-2 infection in hamsters immunized with monovalent and bivalent inactivated vaccines. Int J Biol Sci 2022;18:4781-91. [PMID: 35874942 DOI: 10.7150/ijbs.72109] [Reference Citation Analysis]
3 Kim Y, Gaudreault NN, Meekins DA, Perera KD, Bold D, Trujillo JD, Morozov I, McDowell CD, Chang KO, Richt JA. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization. bioRxiv 2021:2021. [PMID: 34462749 DOI: 10.1101/2021.08.25.457627] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tarke A, Coelho CH, Zhang Z, Dan JM, Yu ED, Methot N, Bloom NI, Goodwin B, Phillips E, Mallal S, Sidney J, Filaci G, Weiskopf D, da Silva Antunes R, Crotty S, Grifoni A, Sette A. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron. Cell 2022;185:847-859.e11. [PMID: 35139340 DOI: 10.1016/j.cell.2022.01.015] [Cited by in Crossref: 71] [Cited by in F6Publishing: 22] [Article Influence: 71.0] [Reference Citation Analysis]
5 Hosch S, Mpina M, Nyakurungu E, Borico NS, Obama TMA, Ovona MC, Wagner P, Rubin SE, Vickos U, Milang DVN, Ayekaba MO, Phiri WP, Daubenberger CA, Schindler T. Genomic Surveillance Enables the Identification of Co-infections With Multiple SARS-CoV-2 Lineages in Equatorial Guinea. Front Public Health 2021;9:818401. [PMID: 35059385 DOI: 10.3389/fpubh.2021.818401] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
6 Bhattacharya M, Sharma AR, Dhama K, Agoramoorthy G, Chakraborty C. Hybrid immunity against COVID-19 in different countries with a special emphasis on the Indian scenario during the Omicron period. International Immunopharmacology 2022;108:108766. [DOI: 10.1016/j.intimp.2022.108766] [Reference Citation Analysis]
7 Jearanaiwitayakul T, Apichirapokey S, Chawengkirttikul R, Limthongkul J, Seesen M, Jakaew P, Trisiriwanich S, Sapsutthipas S, Sunintaboon P, Ubol S. Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract. Viruses 2021;13:2202. [PMID: 34835008 DOI: 10.3390/v13112202] [Reference Citation Analysis]
8 Chakraborty C, Bhattacharya M, Sharma AR, Dhama K, Lee SS. Continent-wide evolutionary trends of emerging SARS-CoV-2 variants: dynamic profiles from Alpha to Omicron. Geroscience 2022. [PMID: 35831773 DOI: 10.1007/s11357-022-00619-y] [Reference Citation Analysis]
9 Agwa SHA, Elghazaly H, El Meteini MS, Yahia YA, Khaled R, Abd Elsamee AM, Darwish RM, Elsayed SM, Hafez H, Mahmoud BS, Em F, Matboli M. Identifying SARS-CoV-2 Lineage Mutation Hallmarks and Correlating Them With Clinical Outcomes in Egypt: A Pilot Study. Front Mol Biosci 2022;9:817735. [DOI: 10.3389/fmolb.2022.817735] [Reference Citation Analysis]
10 Solomon M, Liang C. Human coronaviruses: the emergence of SARS-CoV-2 and management of COVID-19. Virus Research 2022. [DOI: 10.1016/j.virusres.2022.198882] [Reference Citation Analysis]
11 Akaishi T. Insertion-and-Deletion Mutations between the Genomes of SARS-CoV, SARS-CoV-2, and Bat Coronavirus RaTG13. Microbiol Spectr 2022;:e0071622. [PMID: 35658573 DOI: 10.1128/spectrum.00716-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ezzemani W, Kettani A, Sappati S, Kondaka K, El Ossmani H, Tsukiyama-Kohara K, Altawalah H, Saile R, Kohara M, Benjelloun S, Ezzikouri S. Reverse vaccinology-based prediction of a multi-epitope SARS-CoV-2 vaccine and its tailoring to new coronavirus variants. J Biomol Struct Dyn 2022;:1-22. [PMID: 35549819 DOI: 10.1080/07391102.2022.2075468] [Reference Citation Analysis]
13 Reincke SM, Yuan M, Kornau HC, Corman VM, van Hoof S, Sánchez-Sendin E, Ramberger M, Yu W, Hua Y, Tien H, Schmidt ML, Schwarz T, Jeworowski LM, Brandl SE, Rasmussen HF, Homeyer MA, Stöffler L, Barner M, Kunkel D, Huo S, Horler J, von Wardenburg N, Kroidl I, Eser TM, Wieser A, Geldmacher C, Hoelscher M, Gänzer H, Weiss G, Schmitz D, Drosten C, Prüss H, Wilson IA, Kreye J. SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies. Science 2022;375:782-7. [PMID: 35076281 DOI: 10.1126/science.abm5835] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 16.0] [Reference Citation Analysis]
14 Levine Z, Earn DJD. Face masking and COVID-19: potential effects of variolation on transmission dynamics. J R Soc Interface 2022;19:20210781. [PMID: 35506215 DOI: 10.1098/rsif.2021.0781] [Reference Citation Analysis]
15 Zhang JW, Xiong Y, Wang F, Zhang FM, Yang X, Lin GQ, Tian P, Ge G, Gao D. Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CLpro inhibitors for treating COVID-19. Eur J Med Chem 2022;228:114030. [PMID: 34883292 DOI: 10.1016/j.ejmech.2021.114030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Chouati T, Hemlali M, Melloul M, Alaoui-Amine S, Rhoulam S, Ghamaz H, Ouarab M, Askander O, Belayachi L, Touil N, El Mchichi B, Elannaz H, Laraqui A, Elouennass M, Ennibi K, El Fahime E. Coding-Complete Sequence of a SARS-CoV-2 Strain from an Omicron (B.1.1.529+BA.1) Variant Detected in Morocco. Microbiol Resour Announc 2022;:e0006322. [PMID: 35420465 DOI: 10.1128/mra.00063-22] [Reference Citation Analysis]
17 Mandal N, Padhi AK, Rath SL. Molecular insights into the differential dynamics of SARS-CoV-2 variants of concern. Journal of Molecular Graphics and Modelling 2022. [DOI: 10.1016/j.jmgm.2022.108194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
18 Fasching CL, Servellita V, McKay B, Nagesh V, Broughton JP, Sotomayor-Gonzalez A, Wang B, Brazer N, Reyes K, Streithorst J, Deraney RN, Stanfield E, Hendriks CG, Fung B, Miller S, Ching J, Chen JS, Chiu CY. COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 Enzyme. J Clin Microbiol 2022;60:e0026122. [PMID: 35766492 DOI: 10.1128/jcm.00261-22] [Reference Citation Analysis]
19 Abas AH, Marfuah S, Idroes R, Kusumawaty D, Fatimawali, Park MN, Siyadatpanah A, Alhumaydhi FA, Mahmud S, Tallei TE, Emran TB, Kim B. Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19? Molecules 2022;27:2221. [DOI: 10.3390/molecules27072221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Akaishi T, Ishii T. A simulation of geographic distribution for the emergence of consequential SARS-CoV-2 variant lineages. Sci Rep 2022;12:9999. [PMID: 35705624 DOI: 10.1038/s41598-022-14308-5] [Reference Citation Analysis]
21 Sonmezer MC, Dizman GT, Erul E, Sahin TK, Saricaoglu T, Alp A, Tanriover MD, Uzun O, Unal S, Akova M. Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey. Vaccines 2022;10:1140. [DOI: 10.3390/vaccines10071140] [Reference Citation Analysis]
22 Essabbar A, Kartti S, Alouane T, Hakmi M, Belyamani L, Ibrahimi A. IDbSV: An Open-Access Repository for Monitoring SARS-CoV-2 Variations and Evolution. Front Med (Lausanne) 2021;8:765249. [PMID: 34966754 DOI: 10.3389/fmed.2021.765249] [Reference Citation Analysis]
23 Kim Y, Gaudreault NN, Meekins DA, Perera KD, Bold D, Trujillo JD, Morozov I, McDowell CD, Chang KO, Richt JA. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization. Microbiol Spectr 2022;10:e0178921. [PMID: 35638818 DOI: 10.1128/spectrum.01789-21] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Miller NL, Clark T, Raman R, Sasisekharan R. An Antigenic Space Framework for Understanding Antibody Escape of SARS-CoV-2 Variants. Viruses 2021;13:2009. [PMID: 34696440 DOI: 10.3390/v13102009] [Reference Citation Analysis]
25 Vo GV, Bagyinszky E, An SSA. COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development. Microorganisms 2022;10:598. [DOI: 10.3390/microorganisms10030598] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Oliva C, Favato G. From 15 Minutes to 15 Seconds: How the Delta Variant Changed the Risk of Exposure to COVID-19. A Comparative Epidemiological Investigation Using Community Mobility Data From the Metropolitan Area of Genoa, Italy. Front Public Health 2022;10:872698. [DOI: 10.3389/fpubh.2022.872698] [Reference Citation Analysis]
27 Holmes EC, Goldstein SA, Rasmussen AL, Robertson DL, Crits-Christoph A, Wertheim JO, Anthony SJ, Barclay WS, Boni MF, Doherty PC, Farrar J, Geoghegan JL, Jiang X, Leibowitz JL, Neil SJD, Skern T, Weiss SR, Worobey M, Andersen KG, Garry RF, Rambaut A. The origins of SARS-CoV-2: A critical review. Cell 2021;184:4848-56. [PMID: 34480864 DOI: 10.1016/j.cell.2021.08.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 9.0] [Reference Citation Analysis]
28 Arino J, Boëlle PY, Milliken E, Portet S. Risk of COVID-19 variant importation - How useful are travel control measures? Infect Dis Model 2021;6:875-97. [PMID: 34308002 DOI: 10.1016/j.idm.2021.06.006] [Reference Citation Analysis]
29 Arjunan A, Robinson J, Baroutaji A, Tuñón-Molina A, Martí M, Serrano-Aroca Á. 3D Printed Cobalt-Chromium-Molybdenum Porous Superalloy with Superior Antiviral Activity. Int J Mol Sci 2021;22:12721. [PMID: 34884526 DOI: 10.3390/ijms222312721] [Reference Citation Analysis]
30 Zapata-cardona MI, Flórez-álvarez L, Zapata-builes W, Guerra-sandoval AL, Guerra-almonacid CM, Hincapié-garcía J, Rugeles MT, Hernandez JC. Atorvastatin Effectively Inhibits Ancestral and Two Emerging Variants of SARS-CoV-2 in vitro. Front Microbiol 2022;13:721103. [DOI: 10.3389/fmicb.2022.721103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 [DOI: 10.1109/iemcon53756.2021.9623074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
32 Moss P, Berenbaum F, Curigliano G, Grupper A, Berg T, Pather S. Benefit–Risk Evaluation of COVID-19 Vaccination in Special Population Groups of Interest. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.05.067] [Reference Citation Analysis]
33 Okeke ES, Olovo CV, Nkwoemeka NE, Okoye CO, Nwankwo CEI, Onu CJ. Microbial ecology and evolution is key to pandemics: using the coronavirus model to mitigate future public health challenges. Heliyon 2022;8:e09449. [PMID: 35601228 DOI: 10.1016/j.heliyon.2022.e09449] [Reference Citation Analysis]
34 Gerber Z, Daviaud C, Delafoy D, Sandron F, Alidjinou EK, Mercier J, Gerber S, Meyer V, Boland A, Bocket L, Olaso R, Deleuze J. A comparison of high-throughput SARS-CoV-2 sequencing methods from nasopharyngeal samples. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-16549-w] [Reference Citation Analysis]
35 Williams E, Craig K, Chiu C, Davies H, Ellis S, Emerson C, Jamrozik E, Jefford M, Kang GD, Kapulu M, Kolstoe SE, Littler K, Lockett A, Lozano ER, Messer J, Mcshane H, Saenz C, Selgelid MJ, Shah S, Smith PG, Yamazaki N. Ethics review of COVID-19 human challenge studies: a joint HRA/WHO workshop. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.02.004] [Reference Citation Analysis]
36 Alcendor DJ. Targeting COVID Vaccine Hesitancy in Rural Communities in Tennessee: Implications for Extending the COVID-19 Pandemic in the South. Vaccines (Basel) 2021;9:1279. [PMID: 34835210 DOI: 10.3390/vaccines9111279] [Reference Citation Analysis]
37 Yang K, Schuder DN, Ngor AK, Chaput JC. REVEALR-Based Genotyping of SARS-CoV-2 Variants of Concern in Clinical Samples. J Am Chem Soc 2022. [PMID: 35729726 DOI: 10.1021/jacs.2c03420] [Reference Citation Analysis]
38 Oliveira LB, Mwangi VI, Sartim MA, Delafiori J, Sales GM, de Oliveira AN, Busanello ENB, Val FFAE, Xavier MS, Costa FT, Baía-da-Silva DC, Sampaio VS, de Lacerda MVG, Monteiro WM, Catharino RR, de Melo GC. Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in COVID-19 Patients. Front Microbiol 2022;13:844283. [PMID: 35572676 DOI: 10.3389/fmicb.2022.844283] [Reference Citation Analysis]
39 Hassan SS, Basu P, Redwan EM, Lundstrom K, Choudhury PP, Serrano-Aroca A, Azad GK, Aljabali AAA, Palu G, El-Aziz TMA, Barh D, Uhal BD, Adadi P, Takayama K, Bazan NG, Tambuwala M, Lal A, Chauhan G, Baetas-da-Cruz W, Sherchan SP, Uversky VN. Periodically aperiodic pattern of SARS-CoV-2 mutations underpins the uncertainty of its origin and evolution. Environ Res 2021;:112092. [PMID: 34562480 DOI: 10.1016/j.envres.2021.112092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Silva JP, de Lima AB, Alvim LB, Malta FSV, Mendonça CPTB, Fonseca PLC, Moreira FRR, Queiroz DC, Ferreira JGG, Ferreira ACS, Souza RP, Aguiar RS, Zauli DAG. Delta Variant of SARS-CoV-2 Replacement in Brazil: A National Epidemiologic Surveillance Program. Viruses 2022;14:847. [DOI: 10.3390/v14050847] [Reference Citation Analysis]
41 Okamoto KW, Ong V, Wallace R, Wallace R, Chaves LF. When might host heterogeneity drive the evolution of asymptomatic, pandemic coronaviruses? Nonlinear Dyn 2022;:1-23. [PMID: 35757097 DOI: 10.1007/s11071-022-07548-7] [Reference Citation Analysis]
42 Carroll T, Fox D, van Doremalen N, Ball E, Morris MK, Sotomayor-Gonzalez A, Servellita V, Rustagi A, Yinda CK, Fritts L, Port JR, Ma ZM, Holbrook MG, Schulz J, Blish CA, Hanson C, Chiu CY, Munster V, Stanley S, Miller CJ. The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters. PLoS Pathog 2022;18:e1009914. [PMID: 35143587 DOI: 10.1371/journal.ppat.1009914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Calcoen B, Callewaert N, Vandenbulcke A, Kerstens W, Imbrechts M, Vercruysse T, Dallmeier K, Van Weyenbergh J, Maes P, Bossuyt X, Zapf D, Dieckmann K, Callebaut K, Thibaut HJ, Vanhoorelbeke K, De Meyer SF, Maes W, Geukens N. High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium. Viruses 2022;14:1257. [PMID: 35746728 DOI: 10.3390/v14061257] [Reference Citation Analysis]
44 Mustafa S, Alomair LA, Hussein M. In Silico Analysis Using SARS-CoV-2 Main Protease and a Set of Phytocompounds to Accelerate the Development of Therapeutic Components against COVID-19. Processes 2022;10:1397. [DOI: 10.3390/pr10071397] [Reference Citation Analysis]
45 Bansal N, Raturi M, Bansal Y. SARS-CoV-2 variants in immunocompromised COVID-19 patients: The underlying causes and the way forward. Transfus Clin Biol 2021:S1246-7820(21)00532-2. [PMID: 34973463 DOI: 10.1016/j.tracli.2021.12.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Miller IF, Metcalf CJE. Assessing the risk of vaccine-driven virulence evolution in SARS-CoV-2. R Soc open sci 2022;9:211021. [DOI: 10.1098/rsos.211021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Babu MA, Ahmmed MM, Ferdousi A, Mostafizur Rahman M, Saiduzzaman M, Bhatnagar V, Raja L, Poonia RC. The mathematical and machine learning models to forecast the COVID-19 outbreaks in Bangladesh. Journal of Interdisciplinary Mathematics. [DOI: 10.1080/09720502.2021.2015095] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Dos Santos CA, Silva LDC, Souza Júnior MN, Mendes GM, Estrela PFN, de Oliveira KG, de Curcio JS, Resende PC, Siqueira MM, Pauvolid-Corrêa A, Duarte GRM, Silveira-Lacerda EP. Detecting lineage-defining mutations in SARS-CoV-2 using colorimetric RT-LAMP without probes or additional primers. Sci Rep 2022;12:11500. [PMID: 35798777 DOI: 10.1038/s41598-022-15368-3] [Reference Citation Analysis]
49 Hassanin AA, Haidar Abbas Raza S, Ahmed Ujjan J, Aysh Alrashidi A, Sitohy BM, Al-surhanee AA, Saad AM, Mohamed Al -Hazani T, Osman Atallah O, Al Syaad KM, Ezzat Ahmed A, Swelum AA, El-saadony MT, Sitohy MZ. Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions. Saudi Journal of Biological Sciences 2021. [DOI: 10.1016/j.sjbs.2021.12.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 Alradini FA, Alamri F, Aljahany MS, Almuzaini Y, Alsofayan Y, Khan A, Albogami N, Abdulrahim M, Almogbil A, Alahmari A. Post-acute COVID-19 Condition in Saudi Arabia: A National Representative Study. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.03.013] [Reference Citation Analysis]
51 Tosta E. The adaptation of SARS-CoV-2 to humans. Mem Inst Oswaldo Cruz 2022;116:e210127. [PMID: 35019068 DOI: 10.1590/0074-02760210127] [Reference Citation Analysis]
52 Rocha Filho TM, Moret MA, Chow CC, Phillips JC, Cordeiro AJA, Scorza FA, Almeida AG, Mendes JFF. A data-driven model for COVID-19 pandemic - Evolution of the attack rate and prognosis for Brazil. Chaos Solitons Fractals 2021;152:111359. [PMID: 34483500 DOI: 10.1016/j.chaos.2021.111359] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Frederickson ME, Reese AT. Microbial Ecology and Evolution Are Essential for Understanding Pandemics. mBio 2021;12:e0214421. [PMID: 34579579 DOI: 10.1128/mBio.02144-21] [Reference Citation Analysis]
54 Bäuerle A, Jahre L, Teufel M, Jansen C, Musche V, Schweda A, Fink M, Dinse H, Weismüller B, Dörrie N, Junne F, Graf J, Skoda EM. Evaluation of the E-Mental Health Mindfulness-Based and Skills-Based "CoPE It" Intervention to Reduce Psychological Distress in Times of COVID-19: Results of a Bicentre Longitudinal Study. Front Psychiatry 2021;12:768132. [PMID: 34803775 DOI: 10.3389/fpsyt.2021.768132] [Reference Citation Analysis]
55 Wang Y, Chen XY, Yang L, Yao Q, Chen KP. Human SARS-CoV-2 has evolved to increase U content and reduce genome size. Int J Biol Macromol 2022:S0141-8130(22)00270-7. [PMID: 35149094 DOI: 10.1016/j.ijbiomac.2022.02.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Mehra R, Kepp KP. Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused Overview. ACS Infect Dis 2022;8:29-58. [PMID: 34856799 DOI: 10.1021/acsinfecdis.1c00433] [Cited by in Crossref: 8] [Article Influence: 8.0] [Reference Citation Analysis]
57 Wagner CE, Saad-Roy CM, Morris SE, Baker RE, Mina MJ, Farrar J, Holmes EC, Pybus OG, Graham AL, Emanuel EJ, Levin SA, Metcalf CJE, Grenfell BT. Vaccine nationalism and the dynamics and control of SARS-CoV-2. Science 2021;373:eabj7364. [PMID: 34404735 DOI: 10.1126/science.abj7364] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
58 Lippi G, Mattiuzzi C, Henry BM. Updated picture of SARS-CoV-2 variants and mutations. Diagnosis (Berl) 2021. [PMID: 34958184 DOI: 10.1515/dx-2021-0149] [Reference Citation Analysis]
59 Gjorgjievska M, Mehandziska S, Stajkovska A, Pecioska-dokuzovska S, Dimovska A, Durmish I, Ismail S, Pavlovska T, Stojchevska A, Amedi H, Andonova J, Nikolovska M, Velickovikj S, Mitrev Z, Kungulovski I, Kungulovski G. Case Report: Omicron BA.2 Subvariant of SARS-CoV-2 Outcompetes BA.1 in Two Co-infection Cases. Front Genet 2022;13:892682. [DOI: 10.3389/fgene.2022.892682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Shrestha LB, Foster C, Rawlinson W, Tedla N, Bull RA. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission. Rev Med Virol 2022;:e2381. [PMID: 35856385 DOI: 10.1002/rmv.2381] [Reference Citation Analysis]
61 Vadrevu KM, Reddy S, Jogdand H, Ganneru B, Mirza N, Tripathy VN, Singh C, Khalatkar V, Prasanth S, Rai S, Ella R, Blackwelder W, Prasad S, Ella K. Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2–18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study. The Lancet Infectious Diseases 2022. [DOI: 10.1016/s1473-3099(22)00307-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
62 Ahamad S, Ali H, Secco I, Giacca M, Gupta D. Anti-Fungal Drug Anidulafungin Inhibits SARS-CoV-2 Spike-Induced Syncytia Formation by Targeting ACE2-Spike Protein Interaction. Front Genet 2022;13:866474. [PMID: 35401674 DOI: 10.3389/fgene.2022.866474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Murewanhema G, Musuka G, Denhere K, Chingombe I, Mapingure MP, Dzinamarira T. The Landscape of COVID-19 Vaccination in Zimbabwe: A Narrative Review and Analysis of the Strengths, Weaknesses, Opportunities and Threats of the Programme. Vaccines 2022;10:262. [DOI: 10.3390/vaccines10020262] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
64 Goldhill DH, Barclay WS. 2020 Hindsight: Should evolutionary virologists have expected the unexpected during a pandemic? Evolution 2021. [PMID: 34342897 DOI: 10.1111/evo.14317] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]